N-Oleoylethanolamine
SIGMA/O0383 - ~98% (TLC)
Synonym: N-
CAS Number: 111-58-0
Empirical Formula (Hill Notation): C20H39NO2
Molecular Weight: 325.53
EC Number: 203-884-8
MDL Number: MFCD00045972
Linear Formula: C20H39NO2
Product Type: Chemical
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material. This image depicts SKU: O0383-25MG
| assay | ~98% (TLC) |
| form | powder |
| InChI | 1S/C20H39NO2/c1-2-3-4-5-6 |
| InChI key | BOWVQLFMWHZBEF-KTKRTIGZSA |
| Quality Level | 200  |
| SMILES string | O=C(CCCCCCC/C=CCCCCCCCC) |
| solubility | chloroform: 20 mg/mL, clear, colorless |
| storage temp. | −20°C |
| Application: | N-Oleoylethanolamine has been used to study its effects on glucagon-like peptide (GLP)-1RA-mediated anorectic signaling and weight loss. |
| Biochem/physiol Actions: | Oleoylethanolamide (OEA) is a lipid mediator, which helps to control various biological functions, like food intake. It modulates the gene expression in the small intestine. OEA has the ability to initiate several receptors, such as cannabinoid receptor type 1 (CB1), peroxisome proliferator-activated receptors (PPARs) and G protein-coupled receptor 119 (GPR119). |
| Biochem/physiol Actions: | Peroxisome proliferator-activator receptor α (PPARα) agonist |
| General description: | Oleoylethanolamide (OEA) is an endogenous fatty acid ethanolamine. Small intestine cells, adipose tissues, neurons and astrocytes produces OEA. |
| Packaging: | 10, 25 mg in poly bottle |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Purity | ~98% (TLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352204 |